Opinion|Videos|March 14, 2025

How Bispecific Antibodies Are Reshaping Cancer Care

Experts discuss how the availability of bispecific therapies has influenced treatment paradigms in oncology and how bispecifics fit into current treatment algorithms for hematologic malignancies and solid tumors.

Video content above is prompted by the following:

  • How has the availability of bispecific therapies influenced treatment paradigms in oncology?
  • How do bispecifics fit into current treatment algorithms for hematologic malignancies and solid tumors?

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.


Latest CME

Brand Logo

259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo